✦ LIBER ✦

PMS22 ADALIMUMAB, ETANERCEPT AND INFLIXIMAB IN THE TREATMENT OF ANKYLOSING SPONDYLITIS-COST EFFECTIVENESS ANALYSIS IN POLISH SETTINGS

✍ Scribed by T Macioch; M Niewada; W Wrona; D Golicki; T Hermanowski

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PMS16 ADALIMUMAB, ETANERCEPT AND INFLIXI

✍ T Macioch; M Niewada; W Wrona; D Golicki; T Hermanowski 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

Comment on: Infliximab, etanercept and a

✍ Kobelt, G. 📂 Article 📅 2008 🏛 Oxford University Press 🌐 English ⚖ 79 KB

PMS29 Cost Effectiveness of Adalimumab V

✍ A. Marcellusi; M.F. Botteman; S. Rao; M. Cifaldi; C.T. Solem; L. Gitto; P. Giann 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

PMS22 COST-EFFECTIVENESS ANALYSIS OF ETA

✍ J. Vargas-Valencia; M. Sotelo-Guzmán; J.F. Mould-Quevedo; E. Muciño-Ortega; R.M. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

PMS49 Cost-Effectiveness Analysis of Eta

✍ P. Guijarro; C. Crespo; M. Brosa 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

PMS15 COST-EFFECTIVENESS OF THE TREATMEN

✍ E Mucino; R Rivas; L Zapata 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB